Skip to search formSkip to main contentSkip to account menu

DW 2282

Known as: DW-2282, DW2282 
National Institutes of Health

Related topics

Related topics

2 relations

Broader (2)

ImidazolesSulfones

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2001
2001
Induction of G(2)/M phase arrest and apoptosis by a new synthetic anti-cancer agent, DW2282, in promyelocytic leukemia (HL-60) cells.
We studied the effect of DW2282-,[(S)-(+)-4-phenyl-1-[N-(4-aminobenzoyl)-indoline-5-sulfonyl-4,5-dihydro-2-imidazolone… 
1999
1999
Characterization of the anticancer activity of DW2282, a new anticancer agent.
DW2282 [(S)-(+)-4-phenyl-1-[N-(4-aminobenzoyl) indoline-5-sulfonyl]-4,5-dihydro-2-imidazolone].hydrochloride] was derived from… 
1999
1999
Effect of DW2282 on the induction of methemoglobinemia, hypoglycemia or WBC count and hematological changes
DW2282,(S)-(+)-4-phenyl-1-[1-(4-aminobenzoyl)-indoline-5-sulfonyl]-4,5-dihydro-2-imidazolone hydrochloride, is a new anticancer… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)